Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 3, 2023

Ohm Labs Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for OHM LABS, and what generic and branded alternatives to OHM LABS drugs are available?

OHM LABS has eleven approved drugs.

There is one tentative approval on OHM LABS drugs.

Summary for Ohm Labs

US Patents:	0
Tradenames:	9
Ingredients:	8
NDAs:	11

Drugs and US Patents for Ohm Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ohm Labs Inc	EZETIMIBE	ezetimibe	TABLET;ORAL	207311-001	Jun 12, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Ohm Labs Inc	VALSARTAN	valsartan	TABLET;ORAL	077492-001	Jun 26, 2014	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Ohm Labs	IBUPROFEN	ibuprofen	TABLET;ORAL	070818-001	Dec 26, 1985		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Ohm Labs Inc	VALSARTAN	valsartan	TABLET;ORAL	077492-002	Jun 26, 2014	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Ohm Labs	LOPERAMIDE HYDROCHLORIDE	loperamide hydrochloride	TABLET;ORAL	074091-001	Dec 10, 1992		OTC	No	No		⤷ Try a Trial				⤷ Try a Trial
Ohm Labs	IBUPROHM COLD AND SINUS	ibuprofen; pseudoephedrine hydrochloride	TABLET;ORAL	074567-001	Apr 17, 2001		OTC	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

McKesson

Medtronic

AstraZeneca

Baxter

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.